Access to innovative anticancer medicines in China: a national survey on availability, price and affordability.

BMJ Open · 2024 · PMC11057311 · PMID 38670605

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

The overall availability of GBs showed an increasing trend, whereas that of the corresponding originator brands (OBs) showed a decreasing trend, except for lenvatinib.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.